1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Venus Medtech (Hangzhou) Inc.
  6. Company
    2500   CNE100003PJ8

VENUS MEDTECH (HANGZHOU) INC.

(2500)
  Report
Delayed Hong Kong Stock Exchange  -  04:08 2022-06-30 am EDT
17.50 HKD   +6.71%
06/22First American Patient Treated with VenusP-Valve™ Under Compassionate Use
AQ
06/22Venus Medtech Inc. Announces First American Patient Treated with VenusP-Valve Under Compassionate Use
CI
04/13Venus Medtech Completes First-in-Human Study of Bioprosthetic Heart Valve Product
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Venus MedTech (HangZhou) Inc. is a China-based company engaged in the research, development, manufacture and sales of minimally invasive medical devices and auxiliary instruments and equipment for the treatment of heart valve diseases. The Company's main products include the VenusA-Valve System, VenusA-Plus System, VenusA-Pilot System, VenusP-Valve System, TMVR valve, TTVR valve, valvuloplasty balloons V8 / TAV8 and TriGUARD3 Cerebral Embolic Protection Device.

Number of employees : 905 people.
Sales per Business
20202021Delta
VenusA-Valve/VenusA-Plus305.6698.5%488.5397.5% +59.83%
TriGUARD33.761.2%11.312.3% +200.61%
Others0.780.2%1.370.3% +76.43%
HKD in Million
Sales per region
20202021Delta
China305.6698.5%488.5397.5% +59.83%
Others4.541.5%12.672.5% +179.39%
HKD in Million
Managers
Name Title Age Since
Zhen Jun Zi Executive Director & General Manager 51 2012
Haiyue Ma Chief Financial Officer & Joint Secretary 43 2019
Hou-Sen Lim Chief Technology & Operating Officer 48 2018
Wai Chiu Wong Joint Secretary 66 2021
Shakeel Osman Senior Vice President-Sales Europe Region - 2022
Joyce Heo Sales Director-France Region - 2022
Christopher Lee Richardson Head-US Operations 60 2019
Members of the board
Name Title Age Since
Min Zeng Chairman 57 2018
Yan Xiao Chairman-Supervisory Board 38 2018
Wan Yee Lau, Dr. Independent Non-Executive Director 73 2019
Chi Wai Suen Independent Non-Executive Director 56 2019
Ting Yuk Wu Independent Non-Executive Director 66 2018
Hou-Sen Lim Chief Technology & Operating Officer 48 2018
Wing Yu Leung Vice Chairman 51 2013
Wei Wang Member-Supervisory Board 38 2018
Lingling Yang Member-Supervisory Board 59 2018
Zhen Jun Zi Executive Director & General Manager 51 2012
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 441,010,235 351,370,129 79.7% 0 0.0% 79.7%
Stock B 0 1,208 0 0.0% 0 0.0%
Shareholders
NameEquities%
Qiming Venture Partners Ltd. 58,777,980 13.3%
Min Zeng 33,651,618 7.63%
Zhen Jun Zi 32,197,802 7.30%
GIC Pte Ltd. (Investment Management) 22,041,119 5.00%
Fidelity Management & Research Co. LLC 18,670,032 4.23%
JPMorgan Asset Management (Asia Pacific) Ltd. 13,888,500 3.15%
Dcp Ltd. 12,394,252 2.81%
Jiaxing Demenghong Investment Partnership LP 10,628,724 2.41%
Zhong Ou Asset Management Co., Ltd 8,987,500 2.04%
The Vanguard Group, Inc. 8,225,634 1.87%
Company contact information
Venus Medtech (Hangzhou), Inc.
40th Floor
Dah Sing Financial Centre
No. 248 Queen's Road East
Wanchai, Zhejiang 310053

Phone : +86.571.87772183
Web : http://www.venusmedtech.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Venus Medtech (Hangzhou) Inc.